Sands Capital started to build up the position in Karuna Therapeutics in Q2 2019. Since then they sold 579 Thousand shares. The investor completely sold their stake between Q4 2019 and Q3 2021.
Capital Impact Advisors LLC bought a new stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Free Report) during the first quarter, according to its most recen...
The AM Reporter, 8 months agoKaruna Therapeutics (NASDAQ: KRTX ) brought in sales totaling $654 thousand during Q1 according to data provided by Benzinga Pro . However, earnings decrease...
Benzinga, about 1 year agohttps://www.investing.com/news/pro/rbc-capital-on-karuna-therapeutics-inc-via-cerevel-data-karxt-sets-a-high-bar-for-future-muscarinic-agents-432SI-2967257
Investing.com, over 1 year agoKaruna Therapeutics Inc (NASDAQ: KRTX ) shares are trading lower by 11.63% to $200.56 going into the close of Tuesday''s session after the company announced ...
Benzinga, over 1 year ago